Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells

Leukemia Research

Volumn 37, Issue 12, 2013, Pages 1674-1679

  Suzuki, Yuzo ^a   Ito, Shigeki ^a   Sasaki, Ryousei ^a   Asahi, Maki ^a   Ishida, Yoji ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; CIAP 2; Mcl 1; Resveratrol; STAT3

Indexed keywords

4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; CASPASE 3; CYTOTOXIC AGENT; INHIBITOR OF APOPTOSIS PROTEIN 2; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLYPHENOL DERIVATIVE; PROTEIN MCL 1; RESVERATROL; SERINE; STAT3 PROTEIN; TYROSINE;

ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOBLOTTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84888134445     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.09.010     Document Type: Article

References (29)

1. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419.
2. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981, 78:6476-6480.
3. Yoshida M., Miyoshi I., Hinuma I. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982, 79:2031-2035.
4. Yamada Y., Tomonaga M., Fukuda H., Hanada S., Utsunomiya A., Tara M., et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan clinical oncology group study 9303. Br J Haematol 2001, 113:375-382.
5. Murphy E.L., Hanchard B., Figueroa J.P., Gibbs W.N., Lofters W.S., Campbell M., et al. Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989, 43:250-253.
6. Migone T.S., Lin J.X., Cereseto A., Mulloy J.C., O'Shea J.J., Franchini G., et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 1995, 269:79-81.
7. Takemoto S., Mulloy J.C., Cereseto A., Migone T.S., Patel B.K.R., Matsuoka M., et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 1997, 94:13897-13902.
8. Ito S., Oyake T., Murai K., Ishida Y. Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed cells. Leuk Res 2010, 34:352-357.
9. Shanmugam M.K., Kannaiyan R., Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 2011, 63:161-173.
10. Ichikawa H., Nakamura Y., Kashiwada Y., Aggarwal B.B. Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr Pharm Des 2007, 13:3400-3416.
11. Hayashibara T., Yamada Y., Nakayama S., Harasawa H., Tsuruda K., Sugahara K., et al. Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy. Nutr Cancer 2002, 44:192-201.
12. Shishodia S., Aggarwal B.B. Resveratrol: a polyphenol for all seasons 2006, CRC Press Taylor and Francis, Boca Raton, FL.
13. Yang Y.P., Chang Y.L., Huang P.I., Chiou G.Y., Tseng L.M., Chiou S.H., et al. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol 2012, 227:976-993.
14. Roccaro A.M., Leleu X., Sacco A., Moreau A.S., Hatjiharissi E., Jia X., et al. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia. Clin Cancer Res 2008, 14:1849-1858.
15. Bhardwaj A., Sethi G., Vadhan-Raj S., Bueso-Ramos C., Takada Y., Gaur U., et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007, 109:2293-2302.
16. Siddiquee K., Zhang S., Guida W., Blaskovich M.A., Greedy B., Lawrence H.R., et al. Selective chemical probe inhibitor of STAT3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007, 104:7391-7396.
17. Darnell J.E. STATs and gene regulation. Science 1997, 277:1630-1635.
18. Zhong Z., Wen Z., Darnell J.E. STAT3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264:95-98.
19. Zushi S., Shinomura Y., Kiyohara T., Matsuzawa Y. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells. Int J Cancer 1998, 78:326-330.
20. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., et al. STAT3 as an oncogene. Cell 1999, 98:295-303.
21. Rahaman S.O., Harbor P.C., Chernova O., Barnett G.H., Vogelbaum M.A., Haque S.J. Inhibition of constitutively active STAT3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 2002, 21:8404-8413.
22. Epling-Burnette P.K., Liu J.H., Catlett-Falcone R., Turkson J., Ashiro M., Kothapalli R., et al. Inhibition of STAT3 signaling leads to apoptosis of leukemia large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001, 107:351-362.
23. Bingle C.D., Craig R.W., Swales B.M., Singleton V., Zhou P., Whyte M.K. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J Biol Chem 2000, 275:22136-22146.
24. Liu H., Ma Y., Cole S.M., Zander C., Chen K.H., Karras J., et al. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood 2003, 102:344-352.
25. Altieri D.C. Survivin and IAP proteins in cell-death mechanisms. Biochem J 2010, 430:199-205.
26. Bhattacharya S., Ray R.M., Johnson L.R. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis on polyamine-depleted cells. Biochem J 2005, 392:335-344.
27. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998, 17:2215-2223.
28. Derenne S., Monia B., Dean N.M., Taylor J.K., Rapp M.J., Harousseau J.L., et al. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood 2002, 100:194-199.
29. Patel K.R., Scott E., Brown V.A., Gescher A.J., Steward W.P., Brown K. Clinical trials of resveratrol. Ann NY Acad Sci 2011, 1215:161-169.